ArticleThe Lancet regional health. Western Pacific2026
Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort study.
Haonan He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.